SLN
Silence Therapeutics PLC
9.80$
-0.1%
vs. previous close
Closing price · As of: Oct 7, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 89.4% | 86.4% | 93.5% | 93.5% | 93.0% | 92.5% | 91.6% | 89.9% | 91.0% | 90.3% | 89.3% | 88.6% | |
| 60.0% | 57.6% | 58.2% | 58.0% | 36.6% | 59.9% | 35.0% | 25.3% | 55.9% | 8.6% | 4.9% | 67.7% | |
| 60.0% | 57.6% | 78.6% | 79.3% | 76.2% | 72.7% | 73.7% | 69.1% | 69.6% | 64.8% | 60.9% | 67.7% | |
| 0.5% | 20.1% | 9.7% | 0.9% | 0.2% | 0.5% | 9.1% | 12.1% | 15.1% | 18.7% | 19.3% | 8.7% | |
| 0.0% | -15.6% | – | – | – | – | – | – | – | – | – | – | |
| 8.0% | 8.4% | 4.0% | 4.1% | 4.5% | 4.6% | 5.3% | 6.4% | 7.2% | 8.1% | 9.0% | 9.7% | |
| 0.3% | 0.3% | 0.1% | 0.1% | 0.2% | 0.2% | 0.2% | 0.2% | 0.2% | 0.2% | 0.2% | 0.2% | |
| 79.6% | 81.6% | 36.3% | 40.4% | 44.2% | 33.9% | 160.8% | 43.0% | 49.5% | 52.6% | 57.1% | 63.8% | |
| 18.4% | 18.7% | 7.3% | 9.5% | 10.0% | 8.3% | 10.4% | 8.9% | 11.8% | 10.4% | 9.1% | 11.9% | |
| 0.2% | 0.2% | 0.1% | 0.1% | 0.1% | 0.1% | 0.0% | – | 0.1% | 0.1% | 0.1% | 0.1% | |
| 12.2% | 2.8% | 5.4% | 7.9% | 8.4% | 1.8% | 10.2% | 8.7% | 11.6% | 3.4% | 9.0% | 11.9% | |
| 20.4% | 18.4% | 63.7% | 59.6% | 55.8% | 66.1% | -60.8% | 57.0% | 50.5% | 47.4% | 42.9% | 36.2% | |
| -296.7% | -361.6% | -157.3% | -169.7% | -204.7% | -233.9% | 271.2% | -320.7% | -375.2% | -428.0% | -501.7% | -554.1% | |
| 12.7% | 11.1% | 6.0% | 8.3% | 9.3% | 9.6% | 8.5% | 9.5% | 10.7% | 12.0% | 13.7% | 14.8% |
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.